Comprehension of a simplified assent form in a vaccine trial for adolescents: Table 1
Sonia Lee(National Institutes of Health), Craig M. Wilson(University of Alabama at Birmingham), Diane Tucker(Children's Hospital of Los Angeles), James Bethel(Westat (United States)), Coleen K. Cunningham(Duke Medical Center), Dannie Hoffman(University of California, Los Angeles), Sushma Ahmad(Westat (United States)), Bill G. Kapogiannis(Eunice Kennedy Shriver National Institute of Child Health and Human Development), Bret J. Rudy(Columbia University Irving Medical Center), Patricia M. Flynn(St. Jude Children's Research Hospital), Sue Ellen Abdalian
Cited by 21
Related Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.6k
Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant
|New England Journal of Medicine|1996|817
MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs
|Nature Medicine|1999|580
Risk Factors for Perinatal Transmission of Human Immunodeficiency Virus Type 1 in Women Treated with Zidovudine
|New England Journal of Medicine|1999|553
Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention
|New England Journal of Medicine|2016|348